Authors:
Wheat, LJ
Connolly, P
Smedema, M
Brizendine, E
Hafner, R
Citation: Lj. Wheat et al., Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome, CLIN INF D, 33(11), 2001, pp. 1910-1913
Authors:
Kohler, S
Wheat, LJ
Connolly, P
Schnizlein-Bick, C
Durkin, M
Smedema, M
Goldberg, J
Brizendine, E
Citation: S. Kohler et al., Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model, ANTIM AG CH, 44(7), 2000, pp. 1850-1854
Authors:
Goldberg, J
Connolly, P
Schnizlein-Bick, C
Durkin, M
Kohler, S
Smedema, M
Brizendine, E
Hector, R
Wheat, J
Citation: J. Goldberg et al., Comparison of nikkomycin Z with amphotericin B and itraconazole for treatment of histoplasmosis in a murine model, ANTIM AG CH, 44(6), 2000, pp. 1624-1629
Authors:
Connolly, P
Wheat, LJ
Schnizlein-Bick, C
Durkin, M
Kohler, S
Smedema, M
Goldberg, J
Brizendine, E
Loebenberg, D
Citation: P. Connolly et al., Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice, ANTIM AG CH, 44(10), 2000, pp. 2604-2608
Authors:
Connolly, P
Wheat, J
Schnizlein-Bick, C
Durkin, M
Kohler, S
Smedema, M
Goldberg, J
Brizendine, E
Loebenberg, D
Citation: P. Connolly et al., Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice, ANTIM AG CH, 43(2), 1999, pp. 322-328